One notable Healthcare performer in the Fund is Roche (RHHBY, Financial). The company’s pharmaceutical business focuses primarily on biologic and biotech treatments for cancers and immunological diseases—conditions where delaying treatment isn’t an option. Roche also has business units in diagnostics. One of its recently released products is a COVID-19 test with a four-hour turnaround.
From Mairs and Power (Trades, Portfolio) Growth Fund's first-quarter 2020 shareholder letter.
